SCHEMBL366437

SCHEMBL366437

[CH2]CN(CC)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11501923 0.83
SCHEMBL627752 0.79
SCHEMBL4265618 0.77
SCHEMBL24965367 0.73
SCHEMBL4976936 0.73
SCHEMBL8316798 0.71
SCHEMBL4275330 0.69 ALDH1A1 (0.30)
SCHEMBL17085315 0.69
SCHEMBL7964006 0.69
SCHEMBL7964007 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2646043-B1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL INC (US) 2017-02-15 EP claimed
US-20160052972-A1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL INC. 2016-02-25 US claimed
US-20150111815-A1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS S & T GLOBAL INC (US) 2015-04-23 US claimed
US-20140005100-A1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL, INC. 2014-01-02 US claimed
EP-2646043-A1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T Global Inc. (US) 2013-10-09 EP claimed
US-20130210704-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2013-08-15 US claimed
WO-2013028615-A2 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS S&T GOLBAL INC. (US) 2013-02-28 WO claimed
WO-2012075494-A1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL INC. (US) 2012-06-07 WO claimed
WO-2012021796-A2 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL, INC. (US) 2012-02-16 WO claimed
EP-1802650-B1 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION SCYNEXIS INC (US) 2011-10-26 EP claimed
US-7718767-B2 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection SCYNEXIS, INC. (US) 2010-05-18 US claimed
US-20060160727-A1 3-Ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection FLIRI HANS G 2006-07-20 US claimed
US-20060089301-A1 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection SCYNEXIS, INC. 2006-04-27 US claimed
CN-118324867-A Novel cyclosporin derivatives and uses thereof 美国科技环球有限公司 2024-07-12 CN disclosed
CN-109476705-B Novel cyclosporin derivatives and uses thereof 美国科技环球有限公司 2024-02-27 CN disclosed
EP-3831841-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T Global Inc. (US) 2021-06-09 EP disclosed
EP-0915853-A1 SUBSTITUTED 3-PHENYL PYRAZOLES BASF AKTIENGESELLSCHAFT (DE) 1999-05-19 EP disclosed
WO-1999006394-A1 SUBSTITUTED 2-(BENZOARYL)PYRIDINES BASF AKTIENGESELLSCHAFT (DE) 1999-02-11 WO disclosed
WO-1998038169-A1 SUBSTITUTED 3-PHENYL PYRAZOLES BASF AKTIENGESELLSCHAFT (DE) 1998-09-03 WO disclosed
WO-1998005649-A1 SUBSTITUTED 3-PHENYL PYRAZOLES BASF AKTIENGESELLSCHAFT (DE) 1998-02-12 WO disclosed